Applied AI
Product & Design
Democratizing Personalized Care for Oncology Patients
We partnered with OncoRx, a Colorado-based health startup, to help oncologists and patients discover emerging cancer treatments at the right time. Through user-centered design and applied AI, we shaped a platform that turns complex precision oncology data into actionable clinical insight.
We partnered with OncoRx, a Colorado-based health startup, to help oncologists and patients discover emerging cancer treatments at the right time. Through user-centered design and applied AI, we shaped a platform that turns complex precision oncology data into actionable clinical insight.
Applied AI
Product & Design
Democratizing Personalized Care for Oncology Patients
We partnered with OncoRx, a Colorado-based health startup, to help oncologists and patients discover emerging cancer treatments at the right time. Through user-centered design and applied AI, we shaped a platform that turns complex precision oncology data into actionable clinical insight.
ALIGN
We started by deeply understanding the reality of community oncologists. Many see 20–30 patients per day across multiple cancer types, while precision oncology evolves at an overwhelming pace. New clinical trials, FDA approvals, molecular tests, and research papers are published constantly, making it nearly impossible to stay up to date.
Through open interviews with community, specialized, and research-oriented oncologists, as well as pharmaceutical representatives, we mapped current workflows, pain points, and decision-making practices. This allowed us to build a robust user persona and clearly define where technology could truly help.
ALIGN
We started by deeply understanding the reality of community oncologists. Many see 20–30 patients per day across multiple cancer types, while precision oncology evolves at an overwhelming pace. New clinical trials, FDA approvals, molecular tests, and research papers are published constantly, making it nearly impossible to stay up to date.
Through open interviews with community, specialized, and research-oriented oncologists, as well as pharmaceutical representatives, we mapped current workflows, pain points, and decision-making practices. This allowed us to build a robust user persona and clearly define where technology could truly help.
ALIGN
We started by deeply understanding the reality of community oncologists. Many see 20–30 patients per day across multiple cancer types, while precision oncology evolves at an overwhelming pace. New clinical trials, FDA approvals, molecular tests, and research papers are published constantly, making it nearly impossible to stay up to date.
Through open interviews with community, specialized, and research-oriented oncologists, as well as pharmaceutical representatives, we mapped current workflows, pain points, and decision-making practices. This allowed us to build a robust user persona and clearly define where technology could truly help.
PRIORITIZE
From this discovery work, we identified the core challenge: information overload.
Oncologists were forced to jump between multiple sources, manually interpret complex reports, and spend valuable time researching instead of focusing on patient care.
We framed a key question to guide prioritization:
Is the value proposition strong enough to drive oncologists to adopt a new platform?
Based on this, we prioritized solutions that could:
Centralize fragmented medical knowledge
Simplify report interpretation
Surface relevant treatment insights faster
PRIORITIZE
From this discovery work, we identified the core challenge: information overload.
Oncologists were forced to jump between multiple sources, manually interpret complex reports, and spend valuable time researching instead of focusing on patient care.
We framed a key question to guide prioritization:
Is the value proposition strong enough to drive oncologists to adopt a new platform?
Based on this, we prioritized solutions that could:
Centralize fragmented medical knowledge
Simplify report interpretation
Surface relevant treatment insights faster
PRIORITIZE
From this discovery work, we identified the core challenge: information overload.
Oncologists were forced to jump between multiple sources, manually interpret complex reports, and spend valuable time researching instead of focusing on patient care.
We framed a key question to guide prioritization:
Is the value proposition strong enough to drive oncologists to adopt a new platform?
Based on this, we prioritized solutions that could:
Centralize fragmented medical knowledge
Simplify report interpretation
Surface relevant treatment insights faster
Prove
We ran a design sprint to explore and test multiple solution directions. The strongest concepts shifted focus from “more data” to better insight.
Key concepts validated through prototyping and testing included:
Unified reports view
A tailored visualization that makes complex results easier and faster to understand.AI-enhanced insights
Automated insights generated through AI and ML processes to support faster research and interpretation.Centralized medical knowledge
One-click access to multiple research sources, including PubMed, eliminating the need to browse different platforms.
These ideas were iterated and tested with oncologists to ensure they aligned with real-world clinical workflows.
Prove
We ran a design sprint to explore and test multiple solution directions. The strongest concepts shifted focus from “more data” to better insight.
Key concepts validated through prototyping and testing included:
Unified reports view
A tailored visualization that makes complex results easier and faster to understand.AI-enhanced insights
Automated insights generated through AI and ML processes to support faster research and interpretation.Centralized medical knowledge
One-click access to multiple research sources, including PubMed, eliminating the need to browse different platforms.
These ideas were iterated and tested with oncologists to ensure they aligned with real-world clinical workflows.
Prove
We ran a design sprint to explore and test multiple solution directions. The strongest concepts shifted focus from “more data” to better insight.
Key concepts validated through prototyping and testing included:
Unified reports view
A tailored visualization that makes complex results easier and faster to understand.AI-enhanced insights
Automated insights generated through AI and ML processes to support faster research and interpretation.Centralized medical knowledge
One-click access to multiple research sources, including PubMed, eliminating the need to browse different platforms.
These ideas were iterated and tested with oncologists to ensure they aligned with real-world clinical workflows.
Integrate
We refined the product by working closely with oncologists on real cases. By observing how they analyze information, collaborate, and make decisions, we iterated on both interaction flows and information architecture.
Additional capabilities included:
Advanced search and filters by cancer type, keywords, and timeframes
Collaborative virtual boards with HIPAA-compliant sharing and commenting
A user experience designed to fit naturally into existing clinical practices
This ensured the platform felt supportive rather than disruptive.
Integrate
We refined the product by working closely with oncologists on real cases. By observing how they analyze information, collaborate, and make decisions, we iterated on both interaction flows and information architecture.
Additional capabilities included:
Advanced search and filters by cancer type, keywords, and timeframes
Collaborative virtual boards with HIPAA-compliant sharing and commenting
A user experience designed to fit naturally into existing clinical practices
This ensured the platform felt supportive rather than disruptive.
Integrate
We refined the product by working closely with oncologists on real cases. By observing how they analyze information, collaborate, and make decisions, we iterated on both interaction flows and information architecture.
Additional capabilities included:
Advanced search and filters by cancer type, keywords, and timeframes
Collaborative virtual boards with HIPAA-compliant sharing and commenting
A user experience designed to fit naturally into existing clinical practices
This ensured the platform felt supportive rather than disruptive.
Scale
Our holistic, user-driven approach uncovered further opportunities for growth beyond the initial scope. The work established a strong alignment between Arionkoder and OncoRx, creating a clear roadmap for future exploration and expansion.
The result was not just a validated product direction, but a scalable foundation for continued innovation in precision oncology.
Scale
Our holistic, user-driven approach uncovered further opportunities for growth beyond the initial scope. The work established a strong alignment between Arionkoder and OncoRx, creating a clear roadmap for future exploration and expansion.
The result was not just a validated product direction, but a scalable foundation for continued innovation in precision oncology.
Scale
Our holistic, user-driven approach uncovered further opportunities for growth beyond the initial scope. The work established a strong alignment between Arionkoder and OncoRx, creating a clear roadmap for future exploration and expansion.
The result was not just a validated product direction, but a scalable foundation for continued innovation in precision oncology.
“They are, without a doubt, a world-class design and development firm.”
Dave Parkhill
Co-Founder
@
OncoRx
How we helped:
1.
Interviewed oncologists and mapped real-world workflows to identify where technology could meaningfully support clinical decisions.
2.
Designed a tailored reports view that makes complex results easier and faster to interpret.
3.
Used AI and ML processes to surface relevant insights and reduce time spent navigating medical literature.
4.
Enabled one-click access to multiple research sources, including PubMed, eliminating fragmented searches across platforms.
5.
What we did:
6 months of design and development 3 rounds of user testing sessions 4 UI iteration cycles 50+ high-fidelity wireframes
Team
Product Manager & Facilitator UX/UI Designer Back-End Expert Tech Lead
Delivery
UX/UI Design Infrastructure Design Solution Architecture Tech Stack Recommendation Development Forecast
GET STARTED
Ready to make AI useful?
Ready to make AI useful?
Ready to make AI useful?
Turning bold ambition into lasting impact starts with a conversation.
Turning bold ambition into lasting impact starts with a conversation.
© 2025 Arionkoder.
All rights reserved.
Quick Actions
Jump to Value
The Foundry
Email: hello@arionkoder.com
Offices: Americas · EMEA (5 offices)
This site respects your device’s accessibility settings, including Reduce Motion, and reduces animations when that option is enabled.